613 related articles for article (PubMed ID: 15342856)
1. Thimerosal-containing vaccines and autistic spectrum disorder: a critical review of published original data.
Parker SK; Schwartz B; Todd J; Pickering LK
Pediatrics; 2004 Sep; 114(3):793-804. PubMed ID: 15342856
[TBL] [Abstract][Full Text] [Related]
2. Thimerosal exposure in infants and developmental disorders: a retrospective cohort study in the United kingdom does not support a causal association.
Andrews N; Miller E; Grant A; Stowe J; Osborne V; Taylor B
Pediatrics; 2004 Sep; 114(3):584-91. PubMed ID: 15342825
[TBL] [Abstract][Full Text] [Related]
3. Neurodevelopmental disorders following thimerosal-containing childhood immunizations: a follow-up analysis.
Geier D; Geier MR
Int J Toxicol; 2004; 23(6):369-76. PubMed ID: 15764492
[TBL] [Abstract][Full Text] [Related]
4. Prenatal and infant exposure to thimerosal from vaccines and immunoglobulins and risk of autism.
Price CS; Thompson WW; Goodson B; Weintraub ES; Croen LA; Hinrichsen VL; Marcy M; Robertson A; Eriksen E; Lewis E; Bernal P; Shay D; Davis RL; DeStefano F
Pediatrics; 2010 Oct; 126(4):656-64. PubMed ID: 20837594
[TBL] [Abstract][Full Text] [Related]
5. Thimerosal exposure in infants and developmental disorders: a prospective cohort study in the United kingdom does not support a causal association.
Heron J; Golding J;
Pediatrics; 2004 Sep; 114(3):577-83. PubMed ID: 15342824
[TBL] [Abstract][Full Text] [Related]
6. When science is not enough - a risk/benefit profile of thiomersal-containing vaccines.
Clements CJ; McIntyre PB
Expert Opin Drug Saf; 2006 Jan; 5(1):17-29. PubMed ID: 16370953
[TBL] [Abstract][Full Text] [Related]
7. An assessment of the impact of thimerosal on childhood neurodevelopmental disorders.
Geier DA; Geier MR
Pediatr Rehabil; 2003; 6(2):97-102. PubMed ID: 14534046
[TBL] [Abstract][Full Text] [Related]
8. [Lack of association between thimerosal-containing vaccines and autism].
Mrozek-Budzyn D; Majewska R; Kiełtyka A; Augustyniak M
Przegl Epidemiol; 2011; 65(3):491-5. PubMed ID: 22184954
[TBL] [Abstract][Full Text] [Related]
9. Mercury levels in newborns and infants after receipt of thimerosal-containing vaccines.
Pichichero ME; Gentile A; Giglio N; Umido V; Clarkson T; Cernichiari E; Zareba G; Gotelli C; Gotelli M; Yan L; Treanor J
Pediatrics; 2008 Feb; 121(2):e208-14. PubMed ID: 18245396
[TBL] [Abstract][Full Text] [Related]
10. Association between thimerosal-containing vaccine and autism.
Hviid A; Stellfeld M; Wohlfahrt J; Melbye M
JAMA; 2003 Oct; 290(13):1763-6. PubMed ID: 14519711
[TBL] [Abstract][Full Text] [Related]
11. Vaccines and autism: evidence does not support a causal association.
DeStefano F
Clin Pharmacol Ther; 2007 Dec; 82(6):756-9. PubMed ID: 17928818
[TBL] [Abstract][Full Text] [Related]
12. [Mercury in vaccines].
Hessel L
Bull Acad Natl Med; 2003; 187(8):1501-10. PubMed ID: 15146581
[TBL] [Abstract][Full Text] [Related]
13. A meta-analysis epidemiological assessment of neurodevelopmental disorders following vaccines administered from 1994 through 2000 in the United States.
Geier DA; Geier MR
Neuro Endocrinol Lett; 2006 Aug; 27(4):401-13. PubMed ID: 16807526
[TBL] [Abstract][Full Text] [Related]
14. Thimerosal-containing vaccines and autistic spectrum disorder: a critical review of published original data.
Parker S; Todd J; Schwartz B; Pickering L
Pediatrics; 2005 Jan; 115(1):200. PubMed ID: 15630018
[No Abstract] [Full Text] [Related]
15. A comparative evaluation of the effects of MMR immunization and mercury doses from thimerosal-containing childhood vaccines on the population prevalence of autism.
Geier DA; Geier MR
Med Sci Monit; 2004 Mar; 10(3):PI33-9. PubMed ID: 14976450
[TBL] [Abstract][Full Text] [Related]
16. Pervasive developmental disorders in Montreal, Quebec, Canada: prevalence and links with immunizations.
Fombonne E; Zakarian R; Bennett A; Meng L; McLean-Heywood D
Pediatrics; 2006 Jul; 118(1):e139-50. PubMed ID: 16818529
[TBL] [Abstract][Full Text] [Related]
17. Autism and vaccination-the current evidence.
Miller L; Reynolds J
J Spec Pediatr Nurs; 2009 Jul; 14(3):166-72. PubMed ID: 19614825
[TBL] [Abstract][Full Text] [Related]
18. A two-phased population epidemiological study of the safety of thimerosal-containing vaccines: a follow-up analysis.
Geier DA; Geier MR
Med Sci Monit; 2005 Apr; 11(4):CR160-70. PubMed ID: 15795695
[TBL] [Abstract][Full Text] [Related]
19. Of vaccine-autism, thimerosal, and metallothioneins.
Guzzi G
Pediatr Allergy Immunol; 2007 Feb; 18(1):88; author reply 89. PubMed ID: 17295805
[No Abstract] [Full Text] [Related]
20. An evaluation of the effects of thimerosal on neurodevelopmental disorders reported following DTP and Hib vaccines in comparison to DTPH vaccine in the United States.
Geier DA; Geier MR
J Toxicol Environ Health A; 2006 Aug; 69(15):1481-95. PubMed ID: 16766480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
